Clinical trial
A Phase III, Multi-centre, Double-blind, Double-dummy, Randomised, Study to Assess the Superiority of Zegerid® 20 mg vs. Losec® 20 mg in the Rapid Relief of Heartburn Associated With GERD as on Demand Therapy
NCT01493089 is registered in ClinicalTrials.gov with Norgine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase III, Multi-centre, Double-blind, Double-dummy, Randomised, Study to Assess the Superiority of Zegerid® 20 mg vs. Losec® 20 mg in the Rapid Relief of Heartburn Associated With GERD as on Demand Therapy
- Lead sponsor
- Norgine
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- April 30, 2011
- Completion date
- October 31, 2011
- Enrollment
- 239 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.